Paul Kim

FDA's Liberalization Of Mifepristone Dispensing: Securing The Future Of Access To Medical Abortion

Recent Biden Administration Actions On Access To Medication Abortion

A Hatch-Waxman Review: What To Know About The Hatch-Waxman Act As It Turns 39+

President Signs Executive Order To Ensure Essential Medical Products Are Made In The USA

FDA Issues New Guidance To Developers Of COVID-19 Vaccines

FDA Issues New Guidance To Developers Of COVID-19 Drugs And Biological

FDA Issues Guidance On Supply Interruptions And Discontinuance Notification Requirements For Emergency And Life Supporting Drugs

FDA Develops Program To Expedite COVID-19 Drug Review

FDA Will Facilitate Biological Product Development Against COVID-19

What Biopharmaceutical And Medical Device Manufacturers Need To Know About The CARES Act